Company intelligence
Cell Signaling Technology (CST)
CST is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools.
About Cell Signaling Technology (CST)
As a company founded and led by research scientists, we’re working to help unlock the secrets of life. To empower the global scientific community, accelerate biological understanding, and enable personalized medicine. And we believe in the power and promise of science to solve the challenges we face as a global community. Because we’re scientists, we understand your needs as a researcher. We know what it takes to achieve meaningful results— the patience, rigor, sacrifice, and dedication. And we know you have to be able to rely on the tools you use in your investigations, whether in an academic setting or an industry one. That’s why we’re so fanatical about the quality of our antibodies and other products. And why we’re dedicated to providing our customers with the best possible service and support. Engaging in solutions-focused consultation and support is a foundational part of who we are and what we do. Every day, we work to develop innovative, proven solutions that can help you find the answers you’re looking for—answers that can lead to better understanding, diagnosis, and treatment of disease.
Verified activity
Signals from Cell Signaling Technology (CST)
4 published signals
Strategy & Corporate Development
Cell Signaling Technology (CST) is following a detailed, multifaceted, and phased plan to measure all scopes of greenhouse gas emissions and offset the remaining footprint through effective, closely vetted projects.
Reported by Cell Signaling Technology (CST)
Research & Knowledge
Cell Signaling Technology (CST) provides antibody sampler kits to learn whether Bcl-2 family members are contributing to cell death resistance in cancer cells.
Reported by Cell Signaling Technology (CST)
Research & Knowledge
Cell Signaling Technology (CST) published a blog post showing how CST antibodies and matched pairs support protein quantification, TPD degradation and ubiquitination assays, target engagement and ternary complex readouts, and competition formats for small-molecule binding.
Reported by Cell Signaling Technology (CST)
Presence & Recognition
Cell Signaling Technology (CST) announced the hiring of Mike Johnson to lead the company's global research and development team.
Reported by Edward Rehberg